This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

Sonoco Products Company
2/19/2025
Thank you. I now like to turn the call over to Roger Shrum, an interim head of investor relations and communications. You may begin.
Thank you, Rob, and good morning, everyone. Yesterday evening, we issued a news release and posted an investor presentation that reviews Sanoco's fourth quarter and full year results, along with our 2025 guidance. Both are posted on the investor relations sections of our website at sanoco.com. A replay of today's conference call will be available on our website, and we'll post the transcript later this week. If you would turn to slide two, I would remind you that during today's call, we will discuss a number of forward-looking statements based on current expectations, estimates, and projections. These statements are not guarantees of future performance and are subject to certain risks and uncertainties. Therefore, actual results may differ materially. Additionally, today's presentation includes the use of non-GAAP financial measures, which management believes provides useful information to investors about the company's financial condition and results of operation. Further information about the company's use of non-GAAP financial measures, including definitions as well as reconciliation to GAAP measures, is available under the investor relations section of our website. Finally, references to certain financial metrics along with corresponding -over-year comparable results made on this call are on a full company basis except when specifically referred to for continuing operations or for discontinued operations. Joining me this morning are Howard Coker, President and CEO, Roger Fuller, Chief Operating Officer, and Jerry Cheatham, Interim Chief Financial Officer. For today's call, we will have a prepared remarks followed by Q&A. If you will turn to slide four in our presentation, I will now turn the call over to
Howard. Thank you, Roger, and welcome back. 2024 was a milestone year for Sanoco's recreated global leadership in sustainable metal packaging following the December 4th acquisition of EVOSIS, Europe's leading food cans, ends, and closure manufacturer. As slide five shows, we jumpstarted the integration process with day one celebrations with large groups of employees at several EVOSIS facilities. Our teams are now deep in the process of integrating into Sanoco metal packaging EMEA and achieving our two-year $100 million energy target. Also on December 18th, we further transformed our portfolio through the announced vesture of our thermoform and flexible packaging business, the Topan Holdings, for approximately $1.8 billion. We're on track to complete the sale during the second quarter, having now received approval from regulators in the US, Brazil, and the UK. We're continuing a strategic review of our remaining coal chain temperature-assured packaging business to further focus on our metal and paper packaging, consumer and industrial businesses. Moving to slide six, you see the key results for the fourth quarter. Despite persistent price-cost headwinds and the impact of two hurricanes earlier in the quarter, our teams stayed focused on driving solid operating results. Chair will provide the details and drivers for the quarter that adjusted earnings per share, excluding EVOSIS, which we did not project in our guidance, or within our expectations. While EVOSIS recorded a loss in December, it was primarily due to interest expense that was incurred when operations were experienced the normal year-end holiday season slowdown. Rest assured, EVOSIS is a highly profitable, top-quality asset, and results so far in 2025 are certainly meeting our expectations. Overall, in the fourth quarter, Sunoco produced 5% improvement in adjusted EBITDA, and adjusted EBITDA margin expanded to nearly 15%, driven primarily by strong productivity. For all of 2024, we achieved approximately $183 million in productivity savings, equally split between our consumer and industrial segments. As mentioned earlier, some of our operations were impacted by two hurricanes, which hit the Southeast United States in early fourth quarter, including our largest summer point facility in Florida, which had the roof destroyed by Hurricane Milton. Our employees went above and beyond to minimize downtime caused by the storms, while at the same time, taking time to volunteer in their communities to help with cleanup and recovery efforts. Finally, Sunoco generated a better than expected $834 million in operating cashflow, and $456 million in free cashflow. This was the second largest operating cashflow year by Sunoco, and we invested a record $378 million on capital projects focused on growth and productivity. The results of our multi-year invest in our self strategy are demonstrated through our improved productivity. Today's investments are more weighted towards growth. If you look at slide seven, you'll see where we're continuing to invest across our businesses, including expanding greenfield paper can production in Thailand, in Mexico, and in the US. All of these projects are sponsored by customers and will increase organic sales over the next several years. And I should add, the Thailand facility is expected to become one of the world's largest paper can production sites when fully completed over the next
few years.
Also, we're recapitalizing caulk tube production for adhesives and sealants for our customers who are experiencing strong demand as contractors and homeowners repair their homes and businesses from unprecedented storms and fire-related damages. In metal packaging, we're adding capabilities to meeting rising demand for aerosol cans in the US and wet pet food cans in both US and Europe, along with customer-specific cabs and closures projects. And finally, our industrial paper products businesses are continuing to capture targeted growth opportunities and productivity projects in the US and Europe, but we continue to focus on right-sizing select markets. Now, with that brief introduction, let me turn the call over to Jerry Cheatham, who took over the interim CFO role in January, and frankly is doing a great job. I won't go over Jerry's impressive resume, but I've worked with Jerry for most of my career, including when I headed Sanoco's industrial segment, and Jerry served as the group's financial leader. Jerry knows our operations extremely well, and he has a trust and respect of our global finance organization. Jerry, welcome, and please take us through the numbers. Thanks,
Howard. I'm pleased to present the fourth quarter financial results starting on page nine of the presentation. Please note that the results are on an adjusted basis and all growth metrics are on a -over-year basis, unless otherwise stated. The gap to non-gap EPS reconciliation is in the appendix of the presentation, as well as in the press release. As Howard said, 2024 was a milestone year for Sanoco. We made significant progress on our strategy of fewer, bigger businesses that will enable more focused investments to drive value creation through earnings growth and margin improvement. We are confident and excited about the future and expect the leading global market positions of our two core businesses to drive greater efficiency and improve customer support. We grew adjusted EPS, excluding EVOSIS, to $1.17, which was within the lower end of our guidance range. The negative 17 cents related to EVOSIS consisted primarily of interest expense on the related transaction financing for the time period we owned the business in 2024. The .7% EPS improvement year over year was driven by strong operational performance and fixed cost reduction initiatives. Productivity was positive 41 million and marked the eighth consecutive quarter of -over-year productivity improvement. This was further aided by low single-digit volume growth in the consumer and industrial segments and partially offset by the negative impact of price costs and lower volumes in all other businesses. Fourth quarter next sales increased 2% to 1.4 billion, excluding continued operations of 297 million. This favorable change was driven by low single-digit volume gains and the impact of December sales from the EVOSIS acquisition that was completed on December the 4th. This was partially offset by reclassifying the recycling business as a procurement function, lower selling prices and reduced volumes from actions to exit or divest non-strategic positions. Adjusted EBITDA of 247 million was up 5% and adjusted EBITDA margins improved by 46 basis points to 14.9%. Page 10 has our consumer segment results on a continuing operations basis. Consumer sales were up 18% due to the EVOSIS acquisition and favorable volume mix. This was partially offset by lower selling prices. EVOSIS contributed 27 days of sales in December that reflected their normal sales pattern of lower sales during the holiday period. Our global rigid containers and domestic metal packaging business both experienced low single-digit organic volume growth. Consumer adjusted EVODI margins, consumer adjusted EVODI from continuing operations grew 9% year over year due to productivity and fixed cost reductions that was partially offset by negative price cost. Page 11 has our industrial segment results. Industrial sales decreased 4% to 571 million. These results include the reclassification of recycling which reduced sales by 24 million during the quarter. We also completed the exit of our industrial operations in China during the quarter. Adjusting for those actions, industrial sales would have been up .7% year over year. Organic volumes increased by low single digits. Sales were also benefited by low single-digit improvements in selling prices due to index based price resets. Adjusted EVODI margins improved sequentially through the year and were up 250 basis points year over year in the fourth quarter driven by strong productivity. Adjusted EVODI increased by 11 million to 102 million, representing a 12% increase. Page 12 has the results of our all other businesses. All other sales were 88 million and adjusted EVODI was 8 million. The sales and adjusted EVODI results were negatively affected by the divestiture of protective solutions, a customer's new product launch in 2023 that did not repeat in our industrial plastics business, along with flowing sales from COVID vaccine distribution. Turning to page 13, we have our cash flow performance for the year. Strong operating performance drove operating cash flow generation of 834 million for the year. This was the second best year on the heels of a $883 million record year performance in 2023. We invested 378 million for the year on capital projects to enable future growth and drive margin improvement. Now, turning to page 14 and looking ahead to 2025. A four year guidance considers a four year viviosis and one full quarter of TFP. OCC is expected to average $100 for the year. We're expecting a stronger dollar in 2025 and an average effective tax rate of approximately 25%. The euro exchange rate is expected to average 1.055 for the year. Turning to the sales bridge on page 15. We're projecting sales to grow by 21 and a half percent, from 6.6 billion to approximately 8 billion, primarily due to the acquisition of viviosis, net of the TFP divestiture and organic growth in our legacy businesses. In consumer, we expect low single digit organic growth, partially offset by negative index based price reset. For the industrial segment, we also expect low single digit organic volume growth and favorable price due to contractual resets with existing customers. Volume in the all other group of businesses is expected to be mixed with organic growth varying from low single digits to mid teens. Slide 16 provides a summary of our key drivers of our adjusted EPS guidance. We expect to deliver adjusted EPS growth in the range of 19 to 23% above the 2024 EPS of $5.06 that excludes the 17 cents from viviosis in December. Earnings in our legacy businesses are expected to grow by approximately 10%, driven by continued strong operating performance, productivity, organic growth, partially offset by negative price costs due to higher fixed and other expenses. The eviosis acquisition is expected to be 25% accreted and the TFP divestiture is expected to be dilutive in the range of seven to 9%. These projected impact reflect the associated earnings in 2025, net of the interest expense impact from the related financing and expected debt repayment. Non-operational expenses are expected to lower EPS between 25 to 30 cents due to a higher effective tax rate resulting from discrete items in 2024 that we do not expect to repeat. FX headwinds and higher net interest expense. Page 17 presents our CAS flow guidance and key assumptions. We expect to have another strong year of operating CAS flow performance in the range of 800 to 900 million and free CAS flow between 450 to 550 million. We are targeting capital expenditures of approximately 360 million, drive growth and margin expansion opportunities. The ratio of capital spending as a percent of net sales is expected to be slower compared to 2024 due to a higher emphasis on debt repayment. We expect volume growth to lead to a use of networking capital of approximately 25 million. Now with that, I'll turn it back over to Howard for a closing remark.
Right, thanks, Jerry. I'll move to slide 18. Sanoco today is the global leader of value added sustainable metal and fiber consumer and industrial packaging. We've become a simpler, stronger and more sustainable company with products, technology and market presence that positions us to consistently win in the marketplace. Since I was honored by our board of directors five years ago to become CEO, we've gone through a strategic transformation to remove complexity and build pure bigger businesses. That process has led us to the best below margin display and packaging business and other smaller non-for assets. We moved away from resident-based businesses ranging from molded phone products for automobiles to plastic bottles and tray for food, beverage and medical packaging. We did so because we found we could not achieve the necessary scale to consistently win in the marketplace. And we've leaned into our growing aerosol and cans along with caps and closures in the US and MEA. But we now have assembled quality assets and strong market positions. For example, purchasing ball metal pack in January, 2022, we've driven greater than 10% annual growth in adjusted EBITDAF and continued to find opportunities for growth. We believe we can achieve similar results, the devious and are projecting approximately 10% improvement in adjusted EBITDAF for 2025. As mentioned earlier, another key tenant of our strategy is to invest in ourselves. As an example, over the past five years, we've made investments in our global paper can franchise that have resulted in sales growing by nearly 25%, particularly in emerging markets. And with all new paper cans that offer more market differentiation. Our iconic integrated URB industrial paper products business is the global leader of product technology unmatched by our competitors. The continued investment and pruning of certain lower profit businesses and markets, we have grown EBITDAF in North America by approximately 40% since 2020. And finally, the new Sunoco has become a cash generating engine producing approximately $1.7 billion in operating cashflow and $1 billion in free cash over the past two years. After investing in ourselves, our capital allocation strategy is focused on reducing leverage between three times to 3.3 times net debt to adjusted EBITDAF by the end of 2026, utilizing proceeds from divestitures, asset sales and our strong free cashflow. And finally, we expect to achieve an extraordinary 100 consecutive years of returning cash to our shareholders in the form of sector leading dividends. 519 is a graphic representation of what the new Sunoco is expected to achieve in 2025, along with our businesses and served markets. We project sales will grow approximately 20%, between 7.75 billion and 8.0, excuse me, $8 billion. Adjusted EBITDAF is expected to grow approximately 30% to between 1.3 to $1.4 billion. The cashflow for operations will remain strong between 800 and $900 million. Finally, our mix of business is further shifting to more consumer markets and our geographic reach will become more balanced around the world with more than half of our sales still occurring in the United States. Looking forward, we believe our transformed portfolio of world-class consumer industrial packaging businesses are well positioned to serve the challenging changing needs of our diverse global customers. We're off to a solid start to 2025, and I believe our prospects for continued growth, margin improvement and strong cashflow generation will continue to allow us to return greater value to our shareholders. And with that, operator, we're ready to take any questions.
Thank you. We will now begin the question and answer session. If you would like to ask a question, please press star one in your telephone keypad to raise your hand and join the queue. If you would like to withdraw your question, simply press star one again. Your first question comes from a line of George Staffos from Bank of America. Your line is open.
Thanks, good morning. Hi, everyone. Thanks for the details, Jerry, welcome. Roger, great to hear your voice again. Hope everybody's well. I guess, can you talk a little bit about the exit rates or early one queue rates, depending on your perspective that you're seeing across your most important businesses relatedly, can you talk about how EVOSIS is doing relative to the original, I wanna say $430 million of EBITDA guidance on an annualized basis. And lastly, can you talk about how much you're expecting from TFP in the first quarter? Thanks, I might have a quick follow on.
Sure, George, only exit rates. You know, actually the adjusted run rate for EVOSIS, looks like it's gonna be somewhere in the neighborhood of around $390 million for 2024. As we've entered into 2025, our expectation is, and our plan is 10% increase in that number. And that's what we've got built into our guidance. And so far, we're seeing that type of run rate, obviously early with a month and a half behind us, but we're very bullish about the current situation that could go forward there. And then on the remainder of businesses, yeah, we've been seeing sequential improvement, particularly on the metal can business here in North America, slight improvements. The flat is coming out of December on the paper can business. We've seen consecutive improvements, particularly in North America on the industrial business for quarter over quarter over the last three quarters. As we enter the new year, feel uniquely positive about how we're starting things out. Or a slot of uncertainty with what's going on the macro perspective that we control what we can control.
How are you guys doing? Oh, hey Jerry. Yeah, yeah, just as it relates to expectations for TFP in the first quarter, we expect their first quarter 2024 performance to be similar to what we saw in Q4 2024.
Okay, so that would be roughly 20 millionish, 25 million if I remember correctly from the slides. And then just maybe last question, industrial, I recognize you're seeing sequential improvement. Was the business on plan with where you're expecting for the fourth quarter? It was somewhat below our forecast, which is neither here nor there, but just wanna see if there were any things in 4Q that were either positive or negative relative to your guidance. Thank you and I'll turn it over.
Yeah, George, it's Roger. Yeah, as far as industrial in North America, we were very pleased with the fourth quarter. As Howard's already said, we've seen nice growth in our two and core converting operations in North America, with the team doing a really nice job from a service and quality standpoint and winning some shares, especially in the paper mill core area. Paper volumes, URB volumes in North America were basically flat, maybe just slightly. We did see weakness outside of North America and I think that's what you're seeing in the numbers, George. Europe continued to be very soft. We've got work to do there, frankly, from a paper standpoint, from a capacity standpoint, we're working hard on that. As we talked about last quarter, we took a small paper machine out of Greece over the past two quarters, so we're looking hard at the European paper platform and pricing in Europe continues to be difficult from a competitive situation.
And in Asia,
across the board, in our industrial businesses in Asia, very soft volume. We exited China, so you're seeing some of that in the numbers, we've taken a small paper machine out of Indonesia. So frankly, the weaknesses coming from outside of North America were optimistic about North America price cost turned positive in North America in the fourth quarter, which was a very good sign. We see that continuing into the first quarter. So it's outside North America, we're working hard to get costs right and we'll see sequential improvement, but it'll take a little time as we run through 2025.
Okay. Thanks very much, I'll turn it over.
Your next question comes from the line of Anthony Pettinari from Citi, your line is open.
Good morning, this is actually Brian Bergmeyer for Anthony, thank you for taking the question. My first question is just kind of from a high level, I think guidance kind of points to low single digit volume growth in 2025, just curious what that maybe implies specifically for consumer. We maybe consider that to be a little bit above peers or a little bit above maybe some of the blue chip customers, so just curious what's driving that.
Yeah, Brian, you know, if I just look at my charts here, really we're seeing it and the two main businesses left in consumer, the metals business in North America, we saw an aggregate solid, but low single digit type growth over the last year, quarter to quarter to quarter, actually strong in the low single digits for the full year. And we're seeing a pickup in our global paper can business as well. So I talked earlier about capital deployment, you know, a lot of those projects, the new plants in Thailand, Mexico, new lines in the US, some are in the early stages of startup, others will be starting up over a period of time, but, you know, we're not, as we said, low single type digits, we're not forecasting any great recovery, but that's where it's been driven from.
Got it, got it, thanks for that detail. And then maybe just within your metal businesses, you know, are you expecting maybe a better pack season in 2025? I think the North American pack was pretty weak last year. Not curious, I'm curious if you think maybe you have a full recovery or a partial recovery. I know you just said you're not forecasting anything major, but just specifically kind of thinking about North American metal. Thank you, and I'll turn it over.
Yeah, I'd say we're not, slightly better. I mean, beans were impacted. There were a few markets that were impacted, but as you noted, we're kind of holding things in that low single digit up. So we're not forecasting any great type recovery, but certainly we feel like where we are from a share position, particularly on aerosols, we do have visibility of exactly where that growth is coming from. I think if we have a great pack season, that's just upside.
Your next question comes from a line of Matt Roberts from Raymond James. Your line is open.
Hey, good morning, gentlemen. Thank you for taking the questions. If I could first follow up on George's question earlier, I understand there's certainly a lot of moving parts. Typically you do guide one quarter ahead as well. So recognizing there are a lot of moving pieces, wondering if you could help frame EPS for 1Q a little bit better in terms of what you're expecting in terms of volume or any other bridge items there, such as FX impacts or productivity and price costs. Thanks.
Yeah, Matt, you named it right from the very beginning. There are a lot of moving pieces. I think there'll be quite a few follow-up calls to help clean up some of the questions you guys may have. But we opted because of that with all the moving pieces going on right now, disco ops, et cetera, associated with the TFD, et cetera. We've just decided that we would go with an annual forecast and we'll certainly update you on a quarter by quarter basis
as we move through the year. But that pretty much covers it.
Okay, thanks Howard. And certainly understandable there. Maybe on Thermo Safe, I think it was recently in November, you're expected to sign something there in early half of 2025 and close out in the middle of the year. Have there been any changes in the thinking or timing there? I believe you noted volumes in the other, all other segment were negative exiting the year. We've heard some destocking has lingered in pharma and markets. So maybe what are you seeing in terms of volumes in that business? And while Thermo Safe is included in the 2025 guide, are there any assumptions from Thermo Safe in the leverage target? It seems like that changed a bit from the less than 3X that you were thinking previously 24 months after EBSS. Thank you again for taking the questions.
Hey, Matt, it's Roger. Quickly on Thermo Safe, as you mentioned, volumes were a little soft in the fourth quarter and really that's an industry issue. As you said, the pharma sales have slowed some. We're optimistic about 2025, however, if you look at a number of key areas that we're focused on, GLP-1 drugs is one of those. Last year, the supply of those drugs was so tight. There was a very tight restriction on the number of GLP-1 drugs that could be shipped to clinics, doctors offices for samples. And as you've seen, with one of the largest producers of that, they're now shipping direct to consumer and that will positively impact our Thermo Safe business. A lot going on in vaccines, as you know, COVID vaccines have slowed tremendously. We all understand that. But if you look at flu vaccines, with the flu season we've had this year, we expect flu vaccines to be very strong in 2025 and there are new products coming out there like this for the flu vaccine. So we're still optimistic on Thermo Safe. We've not changed what our expectations are there. We expect the best year process to be completed by the end of the year, so that's not changed. And as you've already said, that's built into our deleveraging plan. So we're still optimistic there. The slowdown is an industry issue, but we've got some very specific areas that we're optimistic about in 2025. Roger, Howard,
thank you all again.
Your next question comes from a line of Mark Weintraub from Seaport Research Partners. Your line is open.
Thank you. Two clarifications maybe. One, can you help us with the cash flow bridge from your EPS to your free cash flow per share? Because you have EPS, you know, six to 620, and then you also have CapEx lower than DDNA. Not a whole lot of working capital investment, but your free cash flow per share is, you know, a good bit lower than the EPS. If you could just help us out there, please.
Yeah, I think probably what you're seeing there on the, first of all, in our cash flow guidance, it is reflecting kind of a normal working capital profile, and you're probably seeing the impact of some higher interest expense and a higher effective tax rate sort of pulling that down a little bit. So those would be the two items that may be giving you a little bit of a trouble in reconciling that.
So, Cal, I'll circle back perhaps with you guys on that after, but also on metal overlap, is there anything of significance that we should be, that might be included in the guide one way or the other?
No, Mark, there really isn't pretty much a plethora from a global perspective. So nothing material there to talk about. Okay, great.
And then lastly, on eviosis, thanks for the specifics in terms of like what you're expecting. The numbers you were using, does that include synergies for 2025, or is that 10% increase on the 390, or is that X synergies?
Yeah, I'm glad you asked, Mark. Synergy wise, we had anticipated that we would achieve a fairly significant percentage of the synergies in year one. As you'll recall, when we announced the deal mid-summer, we did not expect that the UK authority, CMA, would take a deep, semi-deep dive into this. So we were not able to close until the first week of December, which really put us on our heels in terms of negotiating annual contracts with our major suppliers. In fact, it turned more into ensuring that we had the necessary raw materials to run the global business. So rather than the majority of the synergies coming in year one, we're estimating about a third of those synergies coming through. With the remainder really flowing into 2026. Not a lot of synergies there, at least in terms of the context of what we had anticipated, but certainly we are extremely bullish, not only on the procurement side, but the deeper we get into the business, through the integration, and the more simplified portfolio being really two substrates now, CANDS and URB and comparative products, the opportunity to drive even further productivity through SG&A, it's pretty exciting over the coming years. I'll just add Mark,
those synergies don't, hey Mark, sorry, those synergies don't necessarily all fall within that idiocy's result as well. That's spread between the other industrial, the other businesses in Europe and some of the metal business in the US. Those synergies are really corporate-wide.
Okay, that's super helpful. Maybe, and I apologize, I know I'm going a little long here, but just the shortfall last year in EBIOSIS relative to what you might have been originally anticipating, anything specific you can point to?
There were quite a few items. Obviously they had some issues with, I say obviously, but they did have some volume issues over in the year, surprise cost issues. Things that happened, I would say that general transaction-related disruptions were a part of it. At the end of the day, as we noted, that we were highly confident in the go-forward outlook of the business. Thank you.
Your next question comes from a line of Mike Roxland from Truist Securities. Your line is open.
Thanks very much for taking the questions and congrats on all the progress. Just wanted to follow up. I think, Roger, you mentioned European weakness in paper and you mentioned having some work to do. Any way you could expound on that and provide some more color around what you're thinking about doing in Europe to improve the business, or maybe just to continue to rationalize assets as you did in Greece.
Yeah, good question. What I was referring to, as you can, well, most people remember six, seven years ago, we started this process in North America of really highly investing in our lowest cost, our best mills, and frankly, just taking out high cost capacity and really just optimizing the network from the paper mill side of the business. And that's really the work I was talking about in Europe. As I said, we took the mill out of Greece and then in my opinion, we just need a more hard focus on really making the difficult decisions around where should we be providing a URB in Europe? How can we be more competitive and accelerating our push to invest in our best mills? And we've got some fantastic mills in Europe. As I said, we've made moves in Greece, we've made a move in Ireland to get some unprofitable capacity out of the system. So in my opinion, we just need to accelerate that. We are accelerating that, it just takes time. And in some cases it takes capital, which we're working through.
God, thank you. Is that something that we should expect will be largely done this year as well? So that when you look at 2026, this will be in hindsight?
You'll see improvements this year in Europe year over year. That's in the guidance and we're confident around that. You'll see more moves around capacity in Europe this year. So yeah, I think you'll see improvements this year and they'll flow into 2026, but we're actively working on it as we speak. Perfect,
great. Just one quick follow up on the audio. How was the integration proceeding thus far? And in the short period of time that you've owned it, anything better than expected, anything not as good? Obviously you mentioned the synergies, which with most of that now coming in 26, or I don't know, 25, I just give him some of the CMA issues, but anything that you've noticed from either positive or negative, and how should we think about the $100 million synergies and potential upside to that?
Yeah, Mike, Roger again. Yeah, I think the integration is going great, frankly. As we expected, we inherited a very strong leadership team. Our cultures are a perfect fit. We're well down the path of sharing best practices across all critical areas of the business. From a customer and market opportunity standpoint, we have some common customers of the large CPGs, the ones you would know, and we think there's a good opportunity to leverage those relationships. And there are some large CPGs that one region serves and the others don't. So we see really good opportunity there. So we're really, the extreme focus is on serving our customers and finding new ways to add value across that metal platform. From a supplier standpoint, the purchasing of direct materials, template, coatings, compounds, is a clear area we're focusing on. Howard's already mentioned, we could not even go to market together until January, but we're putting together strategies as we speak to buy those direct materials globally. From an indirect materials standpoint, logistics, those types of things, pallets, packaging supplies, we're looking across our large European platform. As you know, we've got a large industrial business there, paper can business there, and now with metal, we're looking at indirect transport cost logistics leveraging across that European platform. So we're very confident in the $100 million synergy target to get to that $100 million run rate by the end of 2026. And there's also a significant opportunity to leverage S&A across Europe. So again, shared services is a tremendous opportunity for us across those three businesses, and S&A from an HR and IT, a finance standpoint, serving our industrial, our European businesses in metal, industrial and paper cans. So as I started, I think integration is going great. We're really pleased with where we are. We're confident in the synergies. We got a late start, but we've got firm plans in place to catch up. And I just think the support from our new family members from EVOSIS and the entire Sanoke team has been fantastic. So feel really optimistic about the integration and EVOSIS business coming into Sanoke.
Thanks very much, Roger, and good luck in 25.
And again, if you would like to ask a question, please press star one on your telephone keypad. Your next question comes from a line of George Staffos from Bank of America. Your line is open.
Hi, thanks for taking my following question. So folks, if we could talk about productivity X synergy, if you'd mentioned it earlier in the remarks, forgive me for missing it, but what do you expect for 2025, and how would the mix look across industrial and consumer? Secondly, if we think about the supply chain and Roger talking earlier about how you're trying to work both direct and indirect now, and the work's progressing, any issues to be concerned about relative to trade, to tariffs and the like, how do you feel about your supply of metal? And then totally switching gears in metal itself. Can you give us a bit more color on where you're seeing strength in aerosol? Is it coming more from construction markets? Is it coming elsewhere? And within food, what are you doing to sort of diversify the customer base that you've had traditionally or that that business has had traditionally? Thank you.
So George, if I got all of those, so productivity for 2025, roughly somewhere in the neighborhood between, we're pulling back, I mean, year over year, we've talked about it over and over again, just massive improvements, and it is a year over year calculation. So I think we're like 180 some odd million on top of 130 plus million in 2023. This year, we're taking a more conservative view, again, year over year, around 60 to 65 million in the base business. Hopefully we'll stay on the same kind of track that we've been on.
Yeah, just keep in mind, George, that those flexibles and plastics is out of that. So they've been a strong contributor to the productivity. And productivity is built into the EVOSIS numbers you see, which doesn't fall out into that number that Al is talking about. So there's other pretty significant pieces of productivity in there that don't show up in that 64 million.
Yeah, right. And George, I would add that from a mixed standpoint, the mix of those are pretty balanced between consumer and industrial.
Yeah, and on the tariffs, we'll see how they ultimately end up. We don't like them. Certainly it's an impact here on our US business. And we have mechanisms to pass through without issue, but we're gonna do all we can to minimize the impact of that. And we can, and frankly, the diversity of the supply chain that we now have gives us more opportunities than otherwise we would have. Would say that if you look at it for the remainder outside of the US, keep in mind that in total, roughly 60% of our businesses is non-US and serving local markets, supplied in local markets. So the impact to your point really is on the metal side, the paper side of the business is less of an impact. Again, a little bit going on between Canada and Mexico, but we'll be able to navigate through that without any type of material issue. In terms of strengths, on the aerosol side, yeah, we've just seen the demand on the paint side of the business has increased considerably. I think that has a lot to do with, you can understand the hangover effect of COVID. And I imagine every one of us have got a few paint cans still sitting in our garages, but the paints are up, blue season has been pretty strong. So we're seeing it in disinfectants as well. So yeah, and then on the base business, really focusing on the customers that we have. And historically, there was a share position that the previous strategic owner had that got deteriorated and we just are working harder and harder to satisfy, provide the service quality expected of those customers. And we're seeing that rewarded and slight increases in share.
Thanks very much, good luck in the quarter. Thanks George.
Your next question comes from a line of Richard Carlson from Wells Fargo, your line is open.
Hey, good morning guys, this is Richard in for Gabe Haiti this morning. I just wanted to double click on the 2026 leverage target if you guys could, I know it's too early for guidance, but other than the already disclosed asset sales and the EVOSA synergies, are there any other big pieces that we need to be keeping in mind when we work our models? And then on cap X, there's a good chart you had on slide seven. Should we think about that, you have a continued trend either towards a maintenance level or are you focused more on a percentage of sales basis? Thank you.
Yeah, I'll let Jerry talk about the leverage, but Richard, yeah, the cap X is actually more weighted towards value added. I think if I recall somewhere around 60% of the capital that we're forecasting for this coming year is value added versus maintenance. So you've seen that flip over the last three or four years and I've already talked through a number of major capital initiatives. We've got sponsored greenfield plants going up around the world. So pretty bullish about that understanding that if we invest the costs and we'll see the benefit of these plants as they start ramping up 26, 27, 28. Wanna talk about the leverage?
Yeah, yeah, as we said earlier on the call, we're targeting to get to three to 3.3 times leverage by towards the end of 2026. Obviously we are moving forward with the strategic alternatives for thermal safe, which will, those proceeds would help accelerate that, but we're also believe that strong operating cashflow and strong free cashflow generation will give us confidence that we can get there to that three to 3.3 times by the end of 2026. And on your question on capital, we are trying to tilt more of our capital towards a growth and value generating standpoint. And we do expect to continue to invest in our businesses in that four and a half to five and a half times percent sales.
Great, thanks guys. Best of luck in the quarter.
And that concludes our question and answer session. I will now turn the call back over to Roger Shrum for closing remarks.
I certainly wanna thank everybody for joining us today and we look forward to further discussions with you. We do have some upcoming meetings with investors and conferences that are posted on our website. So stay tuned for other updates and presentations that we have. Again, thank you for your participation and you can disconnect.
This concludes today's conference call. Thank you for joining. You may now disconnect.